Person
Dr. Frank Desiere
CEO of CorTec GmbH, a Freiburg-based clinical-stage neurotechnology company developing the Brain Interchange™ implantable brain-computer interface for stroke rehabilitation. Holds a PhD in molecular biology and an MBA, with a background spanning life sciences and global medtech leadership. Led CorTec through its FDA Breakthrough Device designation and the first human implantation of a German-made fully implantable BCI in the United States.
German · 1 current role
Physical AI footprint (1)
The physical AI companies Dr. is connected to that DEPLOY verifies. The full record is one click away.
- CEO
CorTec is a Freiburg-based clinical-stage neurotechnology company developing the [Brain Interchange](/models/cortec-brain-interchange) BCI system, a fully impla
Current roles (1)
- CorTec CEOSecondary-verified
Sources (3)
- https://www.mobihealthnews.com/news/cortec-becomes-first-german-bci-company-get-fda-breakthrough-designation
- CorTec · https://cortec-neuro.com/cortec-welcomes-dr-frank-desiere-as-chief-executive-officer/
- Cruxx · https://www.thisiscruxx.com/article/leader-in-the-neurotech-spotlight-frank-desiere-ceo-cor-tec-neuro-board-director-chairman/
Deploy Watch
Track Dr. Frank Desiere on Deploy.
We notify you when a verified role changes, a founded-company event lands, or litigation surfaces.